Axovant Sciences

Axovant Sciences

Axovant Sciences

Axovant Sciences is dedicated to delivering novel therapeutic solutions to patients living with dementia today
Type
B2b
Raised
$55M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$55,000,000
Post-IPO debt - 2017
Hercules Capital, Inc.
Team Size
1–10
Employees
Location
Headquarters
$55,000,000 Post-IPO debt
prnewswire

Axovant Sciences Announces $55.0 Million Venture Debt Financing from Hercules Capital

The Motley Fool

Why Axovant Sciences Shares Are Crashing

The Motley Fool

Why Axovant Sciences Skyrocketed 56% in November --